Skip to main content
. 2016 Aug 4;7(39):63177–63188. doi: 10.18632/oncotarget.11050

Figure 4. The comparison of the risk of acute leukemic transformation between h-MDS and NH-MDS patients in subgroups of patients with lower-risk and higher-risk MDS.

Figure 4

The difference in the incidence of acute leukemic transformation between patients with h-MDS and NH-MDS remains statistically significant in lower-risk MDS, with a 5-year acute leukemic transformation rate of 4.8% and 31.4%, respectively A., but not among higher-risk MDS, with an acute leukemic transformation rate of 55.7% and 59.0%, respectively B.